3 | SEC Filings Hub

Filing metadata

Accession number: 0002012430-26-000002
Form type: Form 3
Filer: Milestone Pharmaceuticals Inc.
CIK: CIK 1408443
Filed: Mar 23, 2026
Reporting period: Mar 17, 2026
Description: Initial ownership

Documents

0002012430-26-000002-index.htm

Complete submission

0002012430-26-000002.txt

directory listing

Filed by

Milestone Pharmaceuticals Inc.